Clinical Trial Update: Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intracoronary nicorandil and verapamil to reduce periprocedural myocardial injury in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• nicorandil (intracoronary) (nicorandil)
• verapamyil (verapamil)

Snippet

Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University | Conditions: Coronary Artery Disease | Phase 2 | Status: UNKNOWN